White Paper

Choosing A Formulation And Process Approach To Oral Controlled Release Products

Source: Societalâ„¢ CDMO

By Richard Sidwell, Ph.D., Senior Director of Product Development, Societalâ„¢ CDMO


Choosing the wrong approach to developing and manufacturing your extended release (ER) product can leave you in a blind alley. With no path forward, will you have the money and time to start over? Or will your product simply fall by the wayside?

Developing controlled release formulations may require more time, funds and effort than expected. Enlisting the help of an experienced OCR formulator can quicken the process and ensure your project’s success, especially for complicated formulations requiring multiple active pharmaceutical ingredients (APIs) or complex release patterns. Choosing the best technology and approach for your product can save a lot of frustration and cost on the road to approval.

This article offers some considerations, a framework, and some guiding questions to help you make informed decisions as you work toward a solution.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Delivery Leader